pacritinib
Showing 1 - 25 of 33
KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by
Not yet recruiting
- KSHV Inflammatory Cytokine Syndrome (KICS)
- Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
- Pacritinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 2, 2023
Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg
Recruiting
- Drug Interactions
- CYP450 Cocktail and Transporter Substrates with Pacritinib
- +2 more
-
Austin, TexasPPD - Austin Research Unit
Jan 13, 2023
Hepatic Impairment Trial (oral dose of 200 mg pacritinib twice daily (BID))
Not yet recruiting
- Hepatic Impairment
- oral dose of 200 mg pacritinib twice daily (BID)
- (no location specified)
Sep 23, 2022
T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)
Not yet recruiting
- T-Cell Neoplasm
- Lymphoproliferative Disorders
- Pacritinib
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Oct 6, 2022
Prostate Cancer Trial in Milwaukee (Pacritinib)
Recruiting
- Prostate Cancer
- Pacritinib
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jul 18, 2022
Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)
Active, not recruiting
- Graft Vs Host Disease
- GVHD
- Pacritinib
- +2 more
-
Tampa, Florida
- +1 more
Jul 27, 2022
Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)
Active, not recruiting
- Myelofibrosis
- Pacritinib
-
Antwerpen, Belgium
- +11 more
Aug 19, 2022
Primary Myelofibrosis Trial (Pacritinib)
Withdrawn
- Primary Myelofibrosis
- Pacritinib
- (no location specified)
May 3, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)
Terminated
- Lymphoma, T-Cell, Cutaneous
- +6 more
- Pacritinib
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 20, 2021
COVID19, COVID-19, COVID Trial in United States (Pacritinib, Placebo)
Terminated
- COVID19
- +2 more
- Pacritinib
- Placebo
-
Orange, California
- +20 more
Sep 23, 2021
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
- Pacritinib
-
Phoenix, Arizona
- +61 more
May 5, 2022
Breast Cancer Trial in Singapore (Pacritinib)
Recruiting
- Breast Cancer
- Pacritinib
-
Singapore, SingaporeNational University Hospital
Aug 17, 2020
Myelofibrosis Trial in Munich, Chisinau (Pacritinib)
Completed
- Myelofibrosis
- Pacritinib
-
Munich, Germany
- +1 more
Mar 4, 2020
Drug Interaction Study Trial in Daytona Beach (Pacritinib, Clarithromycin, Pacritinib and Clarithromycin)
Completed
- Drug Interaction Study
- Pacritinib
- +2 more
-
Daytona Beach, FloridaCovance Clinical Research Unit
Jan 27, 2020
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Terminated
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Best Available Therapy
-
Scottsdale, Arizona
- +121 more
Oct 21, 2021
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Terminated
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Best Available Therapy
-
Scottsdale, Arizona
- +80 more
Sep 25, 2020
Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in
Completed
- Recurrent Adult Acute Myeloid Leukemia
- +3 more
- Pacritinib
- +5 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jan 23, 2019
Myeloproliferative Diseases Trial in Houston (drug, behavioral, procedure)
Terminated
- Myeloproliferative Diseases
- Pacritinib
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 4, 2018
Leukemia Trial in Houston (Pacritinib, 5-azacitidine, Decitabine)
Terminated
- Leukemia
- Pacritinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 18, 2018
Myelofibrosis Trial in Munich, Chisinau, Bucharest (Pacritinib)
Completed
- Myelofibrosis
- Pacritinib
-
Munich, Germany
- +2 more
Oct 18, 2018
Acute Myeloid Leukemia (AML) Trial in New York (Pacritinib, Decitabine, Cytarabine)
Terminated
- Acute Myeloid Leukemia (AML)
- Pacritinib
- +2 more
-
New York, New YorkWeill Cornell Medical College
Jun 13, 2018
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
NSCLC, Nonsmall Cell Lung Cancer, NSCLC Trial in Saint Louis (Pacritinib, Erlotinib)
Terminated
- Non-Small Cell Lung Cancer
- +2 more
- Pacritinib
- Erlotinib
-
Saint Louis, MissouriWashington University School of Medicine
Feb 23, 2018
Myeloproliferative Tumor Trial in New York (Vactosertib)
Recruiting
- Myeloproliferative Neoplasm
-
New York, New YorkWeill Medical College of Cornell University
Dec 20, 2021